Precision Biosciences (DTIL) Property, Plant & Equipment (Net) Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -0.31% |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | -60.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.08% |
| Dec 31, 2025 | -50.59% |
| Sep 30, 2025 | -54.70% |
| Jun 30, 2025 | -53.25% |
| Mar 31, 2025 | -51.54% |
| Dec 31, 2024 | -50.29% |
| Sep 30, 2024 | -51.66% |
| Jun 30, 2024 | -49.48% |
| Mar 31, 2024 | -46.17% |
| Dec 31, 2023 | -43.47% |
| Sep 30, 2023 | -37.90% |
| Jun 30, 2023 | -21.37% |
| Mar 31, 2023 | -21.74% |
| Dec 31, 2022 | -33.16% |
| Sep 30, 2022 | -17.61% |
| Jun 30, 2022 | -11.24% |
| Mar 31, 2022 | -5.07% |
| Dec 31, 2021 | 5.95% |